Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial.
Belderbos RA, Baas P, Berardi R, Cornelissen R, Fennell DA, van Meerbeeck JP, Scherpereel A, Vroman H, Aerts JGJV. Belderbos RA, et al. Among authors: van meerbeeck jp. Transl Lung Cancer Res. 2019 Jun;8(3):280-285. doi: 10.21037/tlcr.2019.05.05. Transl Lung Cancer Res. 2019. PMID: 31367541 Free PMC article.
A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
van Meerbeeck JP, Baas P, Debruyne C, Groen HJ, Manegold C, Ardizzoni A, Gridelli C, van Marck EA, Lentz M, Giaccone G. van Meerbeeck JP, et al. Among authors: van marck ea. Cancer. 1999 Jun 15;85(12):2577-82. doi: 10.1002/(sici)1097-0142(19990615)85:12<2577::aid-cncr13>3.3.co;2-j. Cancer. 1999. PMID: 10375105 Clinical Trial.
Caelyx in malignant mesothelioma: a phase II EORTC study.
Baas P, van Meerbeeck J, Groen H, Schouwink H, Burgers S, Daamen S, Giaccone G. Baas P, et al. Ann Oncol. 2000 Jun;11(6):697-700. doi: 10.1023/a:1008346925273. Ann Oncol. 2000. PMID: 10942058 Free article. Clinical Trial.
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.
van Haarst JM, Baas P, Manegold Ch, Schouwink JH, Burgers JA, de Bruin HG, Mooi WJ, van Klaveren RJ, de Jonge MJ, van Meerbeeck JP. van Haarst JM, et al. Among authors: van klaveren rj, van meerbeeck jp. Br J Cancer. 2002 Feb 1;86(3):342-5. doi: 10.1038/sj.bjc.6600118. Br J Cancer. 2002. PMID: 11875695 Free PMC article. Clinical Trial.
A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma.
van Meerbeeck JP, Baas P, Debruyne C, Smit EF, van Klaveren RJ, Galdermans D, Lentz MA, Manegold C, Giaccone G; EORTC Lung Cancer Group. van Meerbeeck JP, et al. Among authors: van klaveren rj. Eur J Cancer. 2002 Apr;38(6):779-83. doi: 10.1016/s0959-8049(01)00428-2. Eur J Cancer. 2002. PMID: 11937311 Clinical Trial.
Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy.
Senan S, Burgers S, Samson MJ, van Klaveren RJ, Oei SS, van Sörnsen de Koste J, Voet PW, Lagerwaard FJ, Maarten van Haarst J, Aerts JG, van Meerbeeck JP. Senan S, et al. Among authors: van klaveren rj, van meerbeeck jp, van sornsen de koste j. Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):999-1006. doi: 10.1016/s0360-3016(02)03028-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 12419425 Clinical Trial.
Improving the specificity of fluorescence bronchoscopy for the analysis of neoplastic lesions of the bronchial tree by combination with optical spectroscopy: preliminary communication.
Bard MP, Amelink A, Skurichina M, den Bakker M, Burgers SA, van Meerbeeck JP, Duin RP, Aerts JG, Hoogsteden HC, Sterenborg HJ. Bard MP, et al. Among authors: van meerbeeck jp. Lung Cancer. 2005 Jan;47(1):41-7. doi: 10.1016/j.lungcan.2004.06.009. Lung Cancer. 2005. PMID: 15603853 Clinical Trial.
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study.
Baas P, Belderbos JS, Senan S, Kwa HB, van Bochove A, van Tinteren H, Burgers JA, van Meerbeeck JP. Baas P, et al. Among authors: van bochove a, van meerbeeck jp, van tinteren h. Br J Cancer. 2006 Mar 13;94(5):625-30. doi: 10.1038/sj.bjc.6602979. Br J Cancer. 2006. PMID: 16465191 Free PMC article. Clinical Trial.
338 results